Spain
· Delayed Price · Currency is EUR Atrys Health Statistics
Total Valuation
Atrys Health has a market cap or net worth of EUR 255.91 million. The enterprise value is 493.32 million.
| Market Cap | 255.91M |
| Enterprise Value | 493.32M |
Important Dates
The next estimated earnings date is Thursday, October 31, 2024.
| Earnings Date | Oct 31, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Atrys Health has 75.94 million shares outstanding.
| Shares Outstanding | 75.94M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.70% |
| Owned by Institutions (%) | 16.00% |
| Float | 41.87M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 293.55 |
| PS Ratio | 1.21 |
| PB Ratio | 0.94 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 32.71, with an EV/FCF ratio of -28.82.
| EV / Earnings | -12.63 |
| EV / Sales | 2.34 |
| EV / EBITDA | 32.71 |
| EV / EBIT | n/a |
| EV / FCF | -28.82 |
Financial Position
The company has a current ratio of 0.98, with a Debt / Equity ratio of 92.34.
| Current Ratio | 0.98 |
| Quick Ratio | 0.80 |
| Debt / Equity | 92.34 |
| Debt / EBITDA | 16.60 |
| Debt / FCF | -14.62 |
| Interest Coverage | -0.02 |
Financial Efficiency
Return on equity (ROE) is -10.79% and return on invested capital (ROIC) is -0.06%.
| Return on Equity (ROE) | -10.79% |
| Return on Assets (ROA) | -0.05% |
| Return on Capital (ROIC) | -0.06% |
| Revenue Per Employee | 101,298 |
| Profits Per Employee | -18,745 |
| Employee Count | 2,084 |
| Asset Turnover | 0.33 |
| Inventory Turnover | 98.90 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -32.24% in the last 52 weeks. The beta is 0.58, so Atrys Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.58 |
| 52-Week Price Change | -32.24% |
| 50-Day Moving Average | 3.44 |
| 200-Day Moving Average | 3.43 |
| Relative Strength Index (RSI) | 46.50 |
| Average Volume (20 Days) | 12,448 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Atrys Health had revenue of EUR 211.11 million and -39.07 million in losses. Loss per share was -0.51.
| Revenue | 211.11M |
| Gross Profit | 55.44M |
| Operating Income | -506,000 |
| Pretax Income | -32.18M |
| Net Income | -39.07M |
| EBITDA | 8.21M |
| EBIT | -506,000 |
| Loss Per Share | -0.51 |
Balance Sheet
The company has 12.81 million in cash and 250.32 million in debt, giving a net cash position of -237.51 million or -3.13 per share.
| Cash & Cash Equivalents | 12.81M |
| Total Debt | 250.32M |
| Net Cash | -237.51M |
| Net Cash Per Share | -3.13 |
| Equity (Book Value) | 271.10M |
| Book Value Per Share | 3.57 |
| Working Capital | -2.01M |
Cash Flow
In the last 12 months, operating cash flow was -12.67 million and capital expenditures -4.44 million, giving a free cash flow of -17.12 million.
| Operating Cash Flow | -12.67M |
| Capital Expenditures | -4.44M |
| Free Cash Flow | -17.12M |
| FCF Per Share | -0.23 |
Margins
Gross margin is 26.26%, with operating and profit margins of -0.24% and -18.51%.
| Gross Margin | 26.26% |
| Operating Margin | -0.24% |
| Pretax Margin | -15.25% |
| Profit Margin | -18.51% |
| EBITDA Margin | 3.89% |
| EBIT Margin | -0.24% |
| FCF Margin | -8.11% |
Dividends & Yields
Atrys Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -15.26% |
| FCF Yield | -6.69% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |